Ivabradine versus bisoprolol
Fazio, G.; Sarulo, F.; Licata, P.; D'Angelo, L.; Passantino, S.; Visconti, C.; Zarcone, P.; Spanò, C.; Novo, G.; Novo, S.
Minerva Cardioangiologica 58(2): 281-282
2010
ISSN/ISBN: 0026-4725 PMID: 20440257 Document Number: 639371
Document emailed within 1 workday
Related Documents
2014: Ivabradine and patients with coronary artery disease: more cardiovascular events Prescrire international 23(155): 295Einecke, D. 2014: SIGNIFY study is a disappointment. Ivabradine cannot stop of the progression of coronary heart disease MMW Fortschritte der Medizin 156(15): 1
Mittal, S.R. 2014: Slow junctional rhythm, QTc prolongation and transient torsades de-pointes following combined use of Ivabradine, Diltiazem and Ranolazine Journal of the Association of Physicians of India 62(5): 426-427
Tatarchenko, I.P.; Pozdniakova, N.V.; Biriuchenko, M.V. 2008: Comparative efficacy of ivabradine and atenolol in correction of clinical and functional parameters in patients with stable effort angina Kardiologiia 48(5): 60-61
Drummond, G. 2000: Bisoprolol in heart failure Hospital Medicine 61(4): 289
Tariovskaya, E.I.; Skibitskiy, V.V.; Malchikova, S.V.; Fendrikova, A.V.; Skibitskiy, A.V.; Sirotenko, D.V. 2015: Pharmacoeconomic Efficacy of a Fixed Combination of Bisoprolol and Amlodipine Kardiologiia 55(4): 25-29
Ikeda, M.; Inagaki, Y.; Iimura, O.; Kuramoto, K.; Takeda, T. 1986: Clinical evaluation of bisoprolol in patients with hypertension: interim report Journal of Cardiovascular Pharmacology 8 Suppl. 11: S139-S142
Unzueta Montoya, A.; Unzueta, A.; Ordóñez Toquero, G.; Villasis Keever, M.A.; Cocoletzi López, J.; Medina Santillán, R. 2000: Comparative study between bisoprolol and metoprolol, combined with hydrochlorothiazide, as antihypertensive therapy Archivos del Instituto de Cardiologia de Mexico 70(6): 589-595
Sárosi, I.; Debreceni, G.; Mühl, D.; Kónyi, A.; Bogár, L.; Tekeres, M.; Tóth, K.; Habon, T.; Czopf, L.; Zámbó, K.; Schmidt, E. 1997: Comparative study of verapamil and bisoprolol in the secondary prevention of myocardial infarction Orvosi Hetilap 138(31): 1939-1945
Fauvel, J.P.; Hadj-Aissa, A.; Laville, M.; Pozet, N.; Bernard, N.; Sassard, J.; Zech, P. 1990: Cardiovascular reactivity to and renal impact of stress and exercise: effects of bisoprolol Journal of Cardiovascular Pharmacology 16(Suppl 5): S19-S24
A, S.A.; R, T.R.; J, S.S. 2008: Simultaneous spectrophotometric estimation of Bisoprolol fumarate and hydrochlorothiazide in tablet dosage form Pakistan Journal of Pharmaceutical Sciences 21(4): 366-369
Wörz, R.; Reinhardt-Benmalek, B.; Föh, M.; Grotemeyer, K.H.; Scharafinski, H.W. 1992: Prevention of migraine using bisoprolol. Results of a double-blind study versus metoprolol Fortschritte der Medizin 110(14): 268-272
Jedliński, I.; Michalski, M.; Dankowski, R.ł; Poprawski, K.; Wierzchowiecki, M.ł; Ozegowski, S.; Pawlak, B. 2002: Transoesophageal Doppler echocardiography provided important parameters in patients with dilated cardiomyopathy during bisoprolol therapy Acta Cardiologica 57(1): 38-40
Striuk, R.I.; Brytkova, I.V.; Bukhonkina, I.M.; Pavlova, L.N. 2008: Clinical efficacy of antihypertensive therapy of pregnant women with arterial hypertension with long acting nifedipine and bisoprolol Kardiologiia 48(4): 29-33
Ivanenko, V.V.; Riazantseva, N.V.; Tarasov, D.L.; Lopatin, I.M. 2004: Effect of beta-Blocker Bisoprolol on Function of Hibernating Myocardium in Patients with Chronic Heart Failure of Ischemic Etiology Kardiologiia 44(7): 57-61
Ageev, F.T.; Zhubrina, E.S.; Ovchinnikov, A.G.; Seredenina, E.M. 2010: Clinical, hemodynamic and neurohumoral effects of switching patients with chronic heart failure from not recommended -adrenoblockers to bisoprolol in ambulatory practice Kardiologiia 50(6): 41-47
Grigor'eva, N.I.; Sharabrin, E.G.; Kuznetsov, A.N.; Mazalov, K.V.; Kontorshchikova, K.N.; Koroleva, E.F. 2009: Effects of beta 1-adrenoblocker bisoprolol on endothelial dysfunction in patients with stable angina pectoris in combination with chronic obstructive pulmonary disease Terapevticheskii Arkhiv 81(3): 28-31
Belenkov, I.N.; Skvortsov, A.A.; Mareev, V.I.; Nasonova, S.N.; Sychev, A.V.; Narusov, O.I.; Baklanova, N.A.; Masenko, V.P. 2003: Clinical, hemodynamic and neurohumoral effects of long-term therapy of patients with severe chronic heart failure with beta-adrenoblocker bisoprolol Kardiologiia 43(10): 10-21
Widimský, Jří. 2015: PATHWAY-2 Study: spironolactone vs placebo, bisoprolol and doxazosin to determine optimal treatment of resistant hypertension. Spironolactone high effective in lowering blood pressure in drug resistant hypertension Vnitrni Lekarstvi 61(12): 1067-1071